Live @ BIO 2008: Innovation, Commercialization, and Protecting Assets
Boston, MA/San Diego, CA - June 19, 2008
Foley Hoag Addresses Key Issues Facing Life Sciences Companies
Foley Hoag LLP released a snapshot of key legal, business, and regulatory issues facing the life sciences industry at the BIO 2008 conference in San Diego. Partners serving a variety of areas, from patent prosecution and strategy to corporate/finance, FDA/regulatory and litigation offer emerging and established companies in the life sciences industry with a roadmap of how to navigate some of the pressing issues facing this highly competitive sector.
Some of the key issues include developing a strong intellectual property portfolio, outsourcing as a business strategy, the regulation of in-vitro diagnostics, follow-on biologics legislation, and patent litigation in front of the International Trade Commission (ITC).
Foley Hoag’s Life Sciences Group provides a full range of services including patent litigation, prosecution and strategy; corporate finance and securities; mergers, acquisitions and strategic alliances; FDA and reimbursement; government strategies; venture capital and emerging companies, and product liability and complex tort.
CATEGORIES
Energy Technology and Renewables, Life Sciences, Healthcare, Technology Transfer & Licensing, Venture Capital & Emerging Companies, Business, Government Strategies, Intellectual Property Litigation, Intellectual Property, International, Medicare Coverage & Reimbursement, Mergers and Acquisitions, Patent